These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8474933)

  • 1. Therapeutic decisions: assessing clinical fit.
    Barriere SL
    Pharmacotherapy; 1993; 13(2 Pt 2):18S-22S. PubMed ID: 8474933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the fluoroquinolones.
    Guay DR
    Pharmacotherapy; 1992; 12(6 Pt 2):71S-85S. PubMed ID: 1480503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current challenges in the treatment of complicated urinary tract infections and prostatitis.
    Wagenlehner FM; Naber KG
    Clin Microbiol Infect; 2006 May; 12 Suppl 3():67-80. PubMed ID: 16669930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoroquinolones.
    Hendershot EF
    Infect Dis Clin North Am; 1995 Sep; 9(3):715-30. PubMed ID: 7490440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoroquinolone antibiotics: properties of the class and individual agents.
    Stratton C
    Clin Ther; 1992; 14(3):348-75; discussion 347. PubMed ID: 1638577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical perspectives on new antimicrobials: focus on fluoroquinolones.
    Talan DA
    Clin Infect Dis; 2001 Mar; 32 Suppl 1():S64-71. PubMed ID: 11249831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoroquinolones: how to use (but not overuse) these antibiotics.
    Sable CA; Scheld WM
    Geriatrics; 1993 Jun; 48(6):41-4, 49-51. PubMed ID: 8500773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symposium on antimicrobial therapy. VII. The fluoroquinolones.
    Greenfield RA
    J Okla State Med Assoc; 1993 Apr; 86(4):166-74. PubMed ID: 8387106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tigecycline: first of a new class of antimicrobial agents.
    Rose WE; Rybak MJ
    Pharmacotherapy; 2006 Aug; 26(8):1099-110. PubMed ID: 16863487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and treatment of community-acquired and hospital-acquired pneumonia.
    Foster MT
    Pharmacotherapy; 1993; 13(2 Pt 2):45S-50S. PubMed ID: 8474938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effective management of complicated urinary tract infections.
    Cox CE
    Adv Ther; 1995; 12(4):222-35. PubMed ID: 10155350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of newer fluoroquinolones for respiratory tract infections and emerging patterns of antimicrobial resistance: data from the SENTRY antimicrobial surveillance program.
    Jones RN; Pfaller MA
    Clin Infect Dis; 2000 Aug; 31 Suppl 2():S16-23. PubMed ID: 10984323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational antibiotic treatment of outpatient genitourinary infections in a changing environment.
    David RD; DeBlieux PM; Press R
    Am J Med; 2005 Jul; 118 Suppl 7A():7S-13S. PubMed ID: 15993672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescribing considerations in fluoroquinolone therapy.
    Gentry LO
    Pharmacotherapy; 1993; 13(2 Pt 2):39S-44S. PubMed ID: 8474937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004).
    Watters AA; Jones RN; Leeds JA; Denys G; Sader HS; Fritsche TR
    J Antimicrob Chemother; 2006 May; 57(5):914-23. PubMed ID: 16549511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of oral fluoroquinolones in patients with respiratory diseases].
    Ishida T
    Kekkaku; 2003 Oct; 78(10):653-9. PubMed ID: 14621574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fluoroquinolones, 10 years later].
    de la Blanchardière A; Carbon C
    Rev Prat; 1993 Sep; 43(14):1830-8. PubMed ID: 8310228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial activity of fluoroquinolones and other antibiotics on 1,116 clinical gram-positive and gram-negative isolates.
    Mascellino MT; Farinelli S; Iegri F; Iona E; De Simone C
    Drugs Exp Clin Res; 1998; 24(3):139-51. PubMed ID: 9825230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of fluoroquinolones: practical considerations.
    Ponte CD; Fisher MA
    Am Fam Physician; 1993 Apr; 47(5):1243-9. PubMed ID: 8465719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and economic evaluation of subsequent infection following intravenous ciprofloxacin or imipenem therapy in hospitalized patients with severe pneumonia.
    Caldwell JW; Singh S; Johnson RH
    J Antimicrob Chemother; 1999 Mar; 43 Suppl A():129-34. PubMed ID: 10225583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.